Janux Therapeutics, Inc. Quarterly Current Ratio in % from Q1 2022 to Q4 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Janux Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q1 2022 to Q4 2024.
  • Janux Therapeutics, Inc. Current Ratio for the quarter ending December 31, 2024 was 5.32K %, a 145% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q4 2024 5.32K +3.15K +145% Dec 31, 2024
Q3 2024 4.46K +2.43K +120% Sep 30, 2024
Q2 2024 4.08K +2.12K +109% Jun 30, 2024
Q1 2024 2.99K +796 +36.4% Mar 31, 2024
Q4 2023 2.17K -228 -9.52% Dec 31, 2023
Q3 2023 2.03K -615 -23.3% Sep 30, 2023
Q2 2023 1.96K -978 -33.3% Jun 30, 2023
Q1 2023 2.19K -1.06K -32.7% Mar 31, 2023
Q4 2022 2.4K Dec 31, 2022
Q3 2022 2.64K Sep 30, 2022
Q2 2022 2.93K Jun 30, 2022
Q1 2022 3.25K Mar 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.